Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The primary aim of the study is to identify a predictive molecular signature for response to
chemotherapy, according to WHO criteria, in patients with non-small cell lung cancer by
studying the transcriptome (miRNAs and mRNAs) and the single nucleotide polymorphism (SNPs)
by using high throughput techniques.